Home > Healthcare > Medical Devices > Therapeutic Devices > U.S. Dialysis Market

U.S. Dialysis Market - By Type (Hemodialysis, Peritoneal Dialysis), Product & Services (Services {Chronic}, Consumables {Dialyzers}, Equipment, {Dialysis Machines, Water Treatment Systems}), End-use (In-center Dialysis, Home Dialysis), & Forecast, 2024 – 2032

  • Report ID: GMI5091
  • Published Date: Sep 2024
  • Report Format: PDF

U.S. Dialysis Market Size

U.S. Dialysis Market size was valued at around USD 28.8 billion in 2023 and is expected to exhibit growth at a CAGR of 5.5% from 2024 to 2032. High market growth can be attributed to the rising number of end-stage renal diseases (ESRD) patients and increasing incidence of diabetes among other contributing factors.
 

U.S. Dialysis Market

To get key market trends   Download Free Sample

The growing prevalence of ESRD is a major driver of expansion in the U.S. dialysis market. ESRD, the final stage of chronic kidney disease (CKD), requires either regular dialysis or a kidney transplant for survival, leading to a heightened demand for dialysis services and equipment. This increase in ESRD cases is largely attributed to the rising incidence of chronic conditions such as diabetes and hypertension, which are primary contributors to kidney damage. Additionally, the aging U.S. population, which experiences a natural decline in kidney function with age, further accelerates the demand for dialysis services among older adults.
 

For instance, according to the U.S. Renal Data System (USRDS) report 2020, there were approximately 808,000 people in the U.S. living with ESRD, with nearly 70% undergoing dialysis treatment. Additionally, the CDC reports that diabetes and hypertension are responsible for 38% and 26% of new ESRD cases, respectively. This rising prevalence of ESRD drives the expansion of the market, as it aims to address the growing needs of this increasing patient population.
 

Dialysis is a medical procedure that artificially performs the functions of the kidneys by removing waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to do so effectively due to kidney failure or chronic kidney disease. Dialysis helps maintain a balance of fluids, electrolytes, and waste in the body, crucial for patients with severe kidney dysfunction.
 

U.S. Dialysis Market Trends

The favourable reimbursement scenario for dialysis treatment is a key factor driving the growth of the market. Government programs such as Medicare provide extensive coverage for dialysis treatment, making it more accessible to patients with ESRD.
 

  • In the U.S., Medicare automatically covers individuals diagnosed with ESRD, regardless of age, ensuring that a large portion of the costs associated with dialysis, including both in-center and home dialysis, are covered. This comprehensive coverage significantly reduces the financial burden on patients, encouraging more individuals to seek and continue necessary treatment, thereby boosting the overall demand for dialysis services and equipment. 
     
  • The broad and reliable coverage provided by Medicare significantly reduces the out-of-pocket expenses for patients, making dialysis treatment more financially accessible and ensuring continuous care for those in need. This ease of access encourages more patients to opt for regular dialysis, thereby driving up the demand for dialysis services and related products.
     
  • Additionally, the reimbursement rates set by Medicare often influence private insurance companies, leading them to offer similar coverage, further expanding access to dialysis treatment across the population. This comprehensive reimbursement framework is instrumental in fostering growth within the market, as it lowers financial barriers for patients and ensures a steady flow of revenue for dialysis providers.
     

U.S. Dialysis Market Analysis

U.S. Dialysis Market, By Type, 2021 - 2032 (USD Billion)
Learn more about the key segments shaping this market   Download Free Sample

Based on type, the market is categorized into hemodialysis and peritoneal dialysis. The hemodialysis segment dominated the market with a revenue of around USD 25.4 billion in 2023.
 

  • Hemodialysis is more commonly used and widely available in dialysis centers across the country. It is the standard treatment for the majority of patients with ESRD, particularly those who may not be candidates for home-based therapies.
     
  • Additionally, many patients and physicians prefer hemodialysis due to the structured nature of the treatment, where care is provided by trained professionals in a clinical setting. This setup provides reassurance to patients, especially those who may be uncomfortable with or unable to manage the complexities of home-based treatments like peritoneal dialysis.
     

Based on product and services, the U.S. dialysis market is categorized into services, consumables, and equipment. The service segment dominated the market in 2023 with a market share of around 78.3%.
 

  • Dialysis is a lifelong, recurrent treatment for patients with ESRD. Patients typically undergo dialysis multiple times per week, leading to a continuous demand for dialysis services, which includes the use of dialysis centers, home dialysis programs, and associated healthcare services. This recurring need makes services the largest and most consistent revenue generator in the dialysis market.
     
  • Moreover, dialysis services encompass not only the procedure itself but also the comprehensive care provided to patients, including regular monitoring, management of treatment schedules, patient education, and emergency care. The extensive support system offered through dialysis services is essential for patient management, driving the dominance of this segment in the market.
     
U.S. Dialysis Market, By End-use (2023)
Learn more about the key segments shaping this market   Download Free Sample

Based on end-use, the U.S. dialysis market is categorized into in-center dialysis and home dialysis. The in-center dialysis segment dominated the market in 2023 and is anticipated to reach USD 38.3 billion by the end of forecast period.
 

  • In-center dialysis is widely available across numerous dialysis centers throughout the U.S. These centers are equipped with the necessary facilities and staffed by trained professionals, making it the more accessible and reliable option for the majority of patients, especially those requiring close medical supervision.
     
  • Furthermore, many patients prefer in-center dialysis because it allows for a structured treatment schedule managed by healthcare professionals, reducing the burden of self-care. For those who may not be comfortable with or capable of performing dialysis at home, in-center treatment provides a safer and more convenient alternative.
     
South Atlantic Dialysis Market, 2021- 2032 (USD Billion)
Looking for region specific data?   Download Free Sample

 The South Atlantic dialysis market accounted for USD 6.5 billion market revenue in 2023 and is anticipated to grow at CAGR of 5.1% between 2024 – 2032 period.
 

  • The South Atlantic which includes states like Florida, Georgia, and North and South Carolina, has a rapidly aging population. Florida, in particular, has one of the highest proportions of elderly residents in the country. As age is a major risk factor for chronic kidney disease (CKD) and ESRD, the increasing number of elderly individuals in the region is leading to a higher demand for dialysis services.
     
  • Moreover, the South Atlantic has experienced significant population growth due to domestic migration, with many individuals relocating to the region for its favorable climate and lower cost of living. This population influx has increased the overall demand for healthcare services, including dialysis, as the region accommodates a larger, more diverse population that may include individuals with chronic health conditions requiring dialysis treatment.
     

Northeast dialysis market is projected to grow remarkably in the coming years.
 

  • In response to the growing number of ESRD patients, there has been a significant push by healthcare providers in the Northeast to expand home dialysis programs. The region’s healthcare systems are increasingly promoting peritoneal dialysis and home hemodialysis as viable options, offering more flexibility for patients and contributing to the overall growth of the dialysis market.
     
  • Further, states in the Northeast, such as Massachusetts and New York, have implemented progressive healthcare policies that improve access to dialysis treatment. These initiatives include expanded Medicaid coverage and state-funded programs that support low-income patients, making dialysis services more accessible and driving market growth in the region.
     

U.S. Dialysis Market Share

The market is characterized by a competitive landscape with numerous national and regional players vying for market share. Major key players are offering advanced products and standardized services contributing to the market expansion. Regional providers are also expanding their services to capture local market segments. Competition drives innovation, improving patient care and operational efficiency. Strategic partnerships, acquisitions, and technological advancements further enhance the competitive dynamics in the market.
 

U.S. Dialysis Market Companies

Some of the eminent market participants operating in the U.S. dialysis industry include:

  • Asahi Kasei Corporation
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • DaVita Inc.
  • Fresenius Medical Care AG & Co.
  • Innovative Renal Care.
  • Medtronic plc
  • Nikkiso Co., Ltd.
  • Nipro Corporation
  • Northwest Kidney Centers
  • Sanderling Renal Services
  • Satellite Healthcare (U.S.)
  • Toray Industries Inc.
  • U.S. Renal Care, Inc.
     

U.S. Dialysis Industry News:

  • In September 2023, B. Braun Medical Inc. announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for AQUAbase nX, a single stage reverse osmosis device providing high-quality water for dialysis patients without the use of chemicals. This approval expanded the company’s competitiveness in the market.
     
  • In January 2021, Innovative Renal Care (IRC) completed the transaction to acquire American Renal Associates Holdings, Inc. This acquisition improved the company’s portfolio and generated revenue for the company.
     

U.S. dialysis market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 to 2032 for the following segments:

Click here to Buy Section of this Report


Market, By Type

  • Hemodialysis
  • Peritoneal dialysis

Market, By Product and Services

  • Services
    • Chronic dialysis
    • Acute dialysis 
  • Consumables
    • Dialyzers
    • Catheters
    • Access products
    • Concentrates
    • Other consumables
  • Equipment
    • Dialysis machines
    • Water treatment systems
    • Other equipment

Market, By End-use

  • In-center dialysis
  • Home dialysis

The above information is provided for the following zones:

  • East North Central
  • West South Central
  • South Atlantic
  • North East
  • East South Central
  • West North Central
  • Pacific Central
  • Mountain States

 

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

U.S. dialysis industry was valued at USD 28.8 billion in 2023 and is expected to exhibit 5.5% CAGR from 2024 to 2032 attributed to the rising number of end-stage renal diseases (ESRD) patients and increasing incidence of diabetes
The hemodialysis type segment in the market recorded USD 25.4 billion in 2023 as it is the standard treatment for the majority of patients with ESRD, particularly those who may not be candidates for home-based therapies.
South Atlantic U.S. dialysis industry size is anticipated to grow at 5.1% CAGR between 2024 and 2032 led by rapidly aging population in Florida, Georgia, and North and South Carolina
Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, DaVita Inc., Fresenius Medical Care AG & Co., Innovative Renal Care., Medtronic plc, Nikkiso Co., Ltd., Nipro Corporation, Toray Industries Inc., and U.S. Renal Care, Inc.

U.S. Dialysis Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 15
  • Tables & Figures: 397
  • Countries covered: 1
  • Pages: 100
 Download Free Sample
 Download Free Sample